Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion type Assertion NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_head.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion wasGeneratedBy ECO_0000203 NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_provenance.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion wasDerivedFrom befree-20150227 NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_provenance.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion SIO_000772 24185104 NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_provenance.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion evidence source_evidence_literature NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_provenance.
- NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_assertion description "[14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848256.RAfSznwrsWFejvfxPOQq301QkuCZWWQGPq-t_2eRVObi4130_provenance.